BioSpace News Archive

Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies to improve the lives of patients with cancer, bacterial diseases and viral infections, announced today a presentation by Emma Christine Jappe, PhD, Senior Scientist, Research & Development, at the Immuno UK conference.

Morphic Therapeutic (Nasdaq: MORF), a biotechnology company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today announced that members of the Morphic leadership team are scheduled to take part in a fireside chat at the Jefferies Virtual Next Generation IBD Therapeutics Summit.

60 Degrees Pharmaceuticals, LLC (60P), a pharmaceutical company focused on developing new medicines for infectious diseases, announced today that a Data Safety Monitoring Board had recommended continuation of its clinical trial that is evaluating the safety and efficacy of ARAKODA® (tafenoquine).

LogicBio Therapeutics, Inc. (Nasdaq:LOGC), today announced that it was selected to present new data from the company’s GeneRide™ platform in a plenary oral presentation and three poster presentations at the upcoming European Society of Gene and Cell Therapy (ESGCT) Virtual Congress 2021.,

Veracyte, Inc. (Nasdaq: VCYT) announced today that it will release its financial results for the second quarter of 2021 after the close of market on Tuesday, November 9.

NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services and global oncology contract research services, announced a transition in the leadership of its Board of Directors.

LifeBio announced its second National Institute on Aging (NIA) Small Business Innovation Research (SBIR) grant of $448,462 to focus on the Alzheimer’s disease population.

GeneThera, Inc. (OTCMKT: GTHR) announced today that it has entered into an exclusive agreement with Cushman & Wakefield (NYSE:CWK) to identify land sites and warehouse buildings in the Denver area in connection with the development of GeneThera Zoonotic Disease Alert Shield (ZIDAS) surveillance network.

Mission Bio, the pioneer in high-throughput single-cell DNA and multi-omics analysis, has launched Tapestri Cell & Gene Therapy Solutions, enabling deep analytical characterization of genotype with phenotype simultaneously for quicker, more efficient workflows.

Sunovion Pharmaceuticals Inc. announced that the Company’s support services program, Sunovion Answers, has been named as a J.D. Power 2021 Certified Customer Service ProgramSM.